Experimental CRISPR therapy reportedly cut LDL cholesterol and triglycerides by about half, with reductions lasting a year
ScienceDaily reports that a single dose lowered LDL cholesterol and triglycerides in patients with difficult-to-treat lipid disorders. At the highest dose, the reductions were 52.5% and 47.8%, respectively.
TLDR
ScienceDaily reports that a single dose of an experimental CRISPR therapy cut LDL cholesterol and triglycerides by about half in patients with difficult-to-treat lipid disorders. The reductions were still present one year later.
Combined views
395
1 Source, first seen 3h ago
1 reposts